Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic/Recurrent Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05700669
What this trial is testing

Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors

Who this might be right for
Metastatic Castration-resistant Prostate CancerRecurrent Epithelial Ovarian CancerBreast Cancer
Valerio Therapeutics 3
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Not applicableActive Not RecruitingNCT07092254
What this trial is testing

Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Daiichi Sankyo 760
Large-scale testing (Phase 3)Ended earlyNCT00010322
What this trial is testing

Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Intarcia Therapeutics
Testing effectiveness (Phase 2)Study completedNCT00334802
What this trial is testing

Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company 62
Early research (Phase 1)Study completedNCT01344031
What this trial is testing

MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor PositiveInvasive Breast CarcinomaRecurrent Breast Carcinoma+1 more
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT00036868
What this trial is testing

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06632405
What this trial is testing

A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 60
Testing effectiveness (Phase 2)Ended earlyNCT00437294
What this trial is testing

Enzastaurin in Combination of Capecitabine to Treat Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 86
Early research (Phase 1)Study completedNCT00307229
What this trial is testing

Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)

Who this might be right for
Metastatic Breast CancerRecurrent Breast Cancer
Ontario Clinical Oncology Group (OCOG) 8
Testing effectiveness (Phase 2)Study completedNCT00266110
What this trial is testing

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT01740427
What this trial is testing

Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

Who this might be right for
Breast Neoplasms
Pfizer 666
Early research (Phase 1)Study completedNCT01245205
What this trial is testing

Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+4 more
National Cancer Institute (NCI) 28
Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)UnknownNCT00006369
What this trial is testing

ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Large-scale testing (Phase 3)Not Yet RecruitingNCT07406542
What this trial is testing

A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breast Cancer

Who this might be right for
Recurrent or Metastatic Breast Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 400
Early research (Phase 1)Study completedNCT01872923
What this trial is testing

Dose Escalating Study for Amphinex-based PCI of Bleomycin.

Who this might be right for
Cutaneous or Sub-cutaneous Malignancies
PCI Biotech AS 3
Large-scale testing (Phase 3)Study completedNCT00002870
What this trial is testing

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 180
Large-scale testing (Phase 3)WithdrawnNCT00301886
What this trial is testing

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer+1 more
SWOG Cancer Research Network
Next Page